Matches in Nanopublications for { ?s ?p "[This Phase I study, Ribozyme Gene Therapy of HIV-1 Infection (UCSD HSC #971072, FDA BB-IND 6405), is a prospective, open-label trial of infusion of autologous gene-altered cells into asymptomatic HIV-1 seropositive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1409639.RA8N0Rsu6fg5DYuFQiuscTdx5qMb7U9jlefh3JoUcHeQ8130_assertion description "[This Phase I study, Ribozyme Gene Therapy of HIV-1 Infection (UCSD HSC #971072, FDA BB-IND 6405), is a prospective, open-label trial of infusion of autologous gene-altered cells into asymptomatic HIV-1 seropositive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1409639.RA8N0Rsu6fg5DYuFQiuscTdx5qMb7U9jlefh3JoUcHeQ8130_provenance.
- NP1409638.RAvFjwbJgiYTwMJoq31m5zZ8I8QT8_GLacxfNSgsltXKI130_assertion description "[This Phase I study, Ribozyme Gene Therapy of HIV-1 Infection (UCSD HSC #971072, FDA BB-IND 6405), is a prospective, open-label trial of infusion of autologous gene-altered cells into asymptomatic HIV-1 seropositive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1409638.RAvFjwbJgiYTwMJoq31m5zZ8I8QT8_GLacxfNSgsltXKI130_provenance.